{"nctId":"NCT00654992","briefTitle":"Effect of Erythropoietin (EPO) in Kidney After Cardiac Surgery","startDateStruct":{"date":"2006-09"},"conditions":["Kidney Failure, Acute"],"count":71,"armGroups":[{"label":"EPO group","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Erythropoietin-Beta"]},{"label":"Placebo group","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Normal Saline"]}],"interventions":[{"name":"Erythropoietin-Beta","otherNames":["recormon"]},{"name":"Normal Saline","otherNames":["0.9% saline"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patients scheduled for elective CABG over age 18\n\nExclusion Criteria:\n\n* Under age 18\n* Emergent CABG\n* Prior exposure to nephrotoxic drug\n* Dialysis patients\n* Uncontrolled hypertension","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"SECONDARY","title":"Change in Estimated Glomerular Filtration Rate (eGFR)","description":"estimated glomerular filtration rate (eGFR)as ml/min/1.73m2","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.5","spread":"7.3"},{"groupId":"OG001","value":"-9.1","spread":"14.5"}]}]}]},{"type":"PRIMARY","title":"Number of Participants Who Had AKI (Acute Kidney Injury)","description":"number of participants who had 50% increase in serum creatinine levels from baseline","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"10","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":null,"commonTop":[]}}}